Search Within

Carol A Aghajanian

Formats
  1. Journal Article (325)
  2. Meeting Abstract (284)
  3. Review (3)
  4. Book Section (1)
  5. Correspondence (1)
  6. Editorial (1)
Groups
  1. Department of Medicine (615)
  2. GDMT, Medicine (615)
  3. Gynecologic Medicine Service (615)
  4. Gynecology Disease Management Team (615)
  5. Solid Tumor Oncology Division (615)
  6. Surgery (229)

More Groups

People
  1. Nadeem Abu-Rustum (126)
  2. Paul Sabbatini (125)
  3. Alexia Iasonos (116)
  4. David Spriggs (105)
  5. Roisin O'Cearbhaill (99)
  6. Martee Hensley (94)

More People

Years
  1. 2025 (24)
  2. 2024 (38)
  3. 2023 (42)
  4. 2022 (45)
  5. 2021 (35)
  6. 2020 (61)

More Years

Publications
  1. Gynecologic Oncology (200)
  2. Journal of Clinical Oncology (150)
  3. International Journal of Gynecological Cancer (57)
  4. Clinical Cancer Research (30)
  5. Annals of Oncology (28)
  6. Cancer (15)

More Publications

Publishers
  1. Elsevier B.V. (204)
  2. American Society of Clinical Oncology (156)
  3. Lippincott Williams & Wilkins (59)
  4. American Association for Cancer Research (54)
  5. Oxford University Press (30)
  6. Elsevier Inc. (21)

More Publishers

Results (615)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Lenvatinib (LEN) plus pembrolizumab (PEMBRO) for early-line treatment of advanced/recurrent endometrial cancer (EC)
    Meeting Abstract

    Makker, V.; Taylor, M. H.; Aghajanian, C.; Oaknin, A.; Mier, J.; Cohn, A. L.; Romeo, M.; Bratos, R.; Brose, M. S.; DiSimone, C.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Olaparib treatment in patients (pts) with platinum-sensitive relapsed (PSR) ovarian cancer (OC) by BRCA mutation (BRCAm) and homologous recombination deficiency (HRD) status: Phase II LIGHT study
    Meeting Abstract

    Cadoo, K. A.; Simpkins, F.; Mathews, C. A.; Kabil, N.; Bennett, J.; Aghajanian, C.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • The impact of poly ADP ribose polymerase (PARP) inhibitors on clonal hematopoiesis
    Meeting Abstract

    Bolton, K. L.; Moukarzel, L. A.; Ptashkin, R.; Gao, T.; Patel, M.; Caltabellotta, N.; Braunstein, L. Z.; Aghajanian, C.; Hyman, D. M.; Berger, M. F.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • PFS by blinded independent central review (BICR) in the VELIA trial of veliparib (V) plus carboplatin/paclitaxel (CP) and as monotherapy in newly diagnosed patients (pts) with high-grade serous ovarian cancer (HGSC)
    Meeting Abstract

    Aghajanian, C.; Bookman, M. A.; Fleming, G. F.; Brady, M. F.; Swisher, E. M.; Steffensen, K. D.; Friedlander, M.; Okamoto, A.; Moore, K. N.; Sullivan, D. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Timing of adverse events during maintenance treatment with rucaparib for recurrent ovarian cancer in the phase III ARIEL3 study
    Meeting Abstract

    Dean, A.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Colombo, N.; Weberpals, J.; Clamp, A. R.; Scambia, G.; Leary, A.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Maintenance olaparib for patients (pts) with newly diagnosed, advanced ovarian cancer (OC) and a BRCA mutation (BRCAm): 5-year (y) follow-up (f/u) from SOLO1
    Meeting Abstract

    Banerjee, S.; Moore, K. N.; Colombo, N.; Scambia, G.; Kim, B. G.; Oaknin, A.; Friedlander, M.; Lisyanskaya, A.; Floquet, A.; Leary, A.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Veliparib with carboplatin and paclitaxel in frontline high-grade serous ovarian cancer (HGSOC): Efficacy and safety of paclitaxel weekly and every 3 weeks in the VELIA study
    Meeting Abstract

    Okamoto, A.; Fleming, G.; Bookman, M.; Brady, M. F.; Swisher, E. M.; Steffensen, K. D.; Cloven, N. G.; Enomoto, T.; O'Malley, D. M.; Van Le, L.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer
    Journal Article

    Makker, V.; Taylor, M. H.; Aghajanian, C.; Oaknin, A.; Mier, J.; Cohn, A. L.; Romeo, M.; Bratos, R.; Brose, M. S.; DiSimone, C.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancer
    Journal Article

    Liu, Y. L.; Zhou, Q. C.; Iasonos, A.; Filippova, O. T.; Chi, D. S.; Zivanovic, O.; Sonoda, Y.; Gardner, G.; Broach, V.; Ocearbhaill, R.; more...
    International Journal of Gynecological Cancer (2020)

    Fulltext@MSK | Save
  • Impact of provider volume on front-line chemotherapy guideline compliance and overall survival in elderly patients with advanced ovarian cancer
    Journal Article

    Aviki, E. M.; Lavery, J. A.; Long Roche, K.; Cowan, R.; Dessources, K.; Basaran, D.; Green, A. K.; Aghajanian, C. A.; O'Cearbhaill, R.; Jewell, E. L.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save